サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1494468

北米の医薬品販売受託機関：2030年市場予測- 地域別分析- サービス、モジュール、治療分野、エンドユーザー別

North America Pharmaceutical Contract Sales Organizations Market Forecast to 2030 - Regional Analysis - by Services, Modules, Therapeutic Area, and End User
出版日: | 発行: The Insight Partners | ページ情報: 英文 86 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.53円
北米の医薬品販売受託機関：2030年市場予測- 地域別分析- サービス、モジュール、治療分野、エンドユーザー別
出版日: 2024年04月05日
発行: The Insight Partners
ページ情報: 英文 86 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の医薬品販売受託機関市場は、2022年の39億8,729万米ドルから2030年には76億1,412万米ドルに成長すると予測されています。2022年から2030年までのCAGRは8.4%を記録すると推定されます。

デジタル技術の統合が北米の医薬品販売受託機関市場を牽引

デジタル技術の導入が進み、医薬品販売受託機関（CSO）市場の変革が加速しています。この根本的な変化は、ダイナミックに変化する医薬品市場への戦術的対応の必要性を浮き彫りにしています。営業業務の合理化、生産性の向上、デジタル化が進むヘルスケア環境の複雑性を乗り切るために不可欠な要素は、CSOにデジタルツールやテクノロジーを統合することです。先進的な顧客関係管理ツール、人工知能、データ分析により、CSOは貴重な洞察を得て、営業戦略をカスタマイズし、ヘルスケア専門家とより深い関係を築くことができます。情報伝達のスピードアップに加え、デジタルプラットフォームのシームレスな統合により、市場動向や法改正へのリアルタイムな対応が可能になります。製薬企業CSOの状況におけるこのような技術的変化は、単なる流行にとどまらず、営業戦術の開発・実施方法の根本的な再定義を意味します。デジタル技術の採用は、CSOをイノベーションの最前線に位置づける。デジタル技術の採用により、CSOはイノベーションの最前線に立つことになり、ヘルスケア業界を席巻している大規模なデジタル・トランスフォーメーションに沿った、より応答性の高い環境が促進されます。製薬企業CSOは、技術的専門知識、戦略的俊敏性、製薬エコシステムの現代的要求に対する明確な認識の融合によって推進されるデジタル化の力を活用し続けるため、市場は持続的な成長を遂げる位置にあります。

北米の医薬品販売受託機関市場の概要

北米の医薬品販売受託機関市場は、米国、カナダ、メキシコに区分されます。2022年には、米国がこの地域で最大の市場シェアを占めており、予測期間中もその優位性が続くと予想されます。北米の医薬品販売業務受託市場は、販売業務受託企業による新技術の採用、製薬企業による低分子医薬品やバイオ医薬品の販売促進への関心の高まり、社内販売業務で発生するコストの削減への注力の高まりが、北米の医薬品販売業務受託市場の成長を促進する主な要因となっているため、成長が見込まれています。新薬の上市数は時間の経過とともに急増しています。IQVIAの研究開発動向に関する報告書によると、2021年には世界で84の新規活性化合物が導入され、これは過去5年間に導入された数の2倍にあたる。国際的な医薬品発売の増加に伴い、販売受託サービスの需要も高まると予想されます。医薬品販売受託機関市場では、北米が最大のシェアを占めています。EPS Corp.、IQVIA, Inc.、Axxelusなどの主要企業がこの地域の市場を牽引しています。

北米の医薬品販売受託機関市場の収益と2030年までの予測（金額）

北米の医薬品販売受託機関市場のセグメンテーション

北米の医薬品販売受託機関市場は、サービス、モジュール、治療分野、エンドユーザー、国に区分されます。

サービス別に見ると、北米の医薬品販売受託機関市場は商用サービスと非商用サービスに二分されます。2022年の北米の医薬品販売受託機関市場では、商業サービス分野が大きなシェアを占めています。

モジュールに基づくと、北米の医薬品販売受託機関市場はシンジケートモジュールと専用モジュールに二分されます。2022年の北米の医薬品販売受託機関市場では、シンジケートモジュール分野が大きなシェアを占めています。

北米の医薬品販売受託市場は、治療分野別に、心血管疾患、腫瘍、代謝疾患、神経、整形外科疾患、感染症、その他に区分されます。2022年の北米の医薬品販売受託機関市場では、がん分野が最大のシェアを占めています。

エンドユーザー別に見ると、北米の医薬品販売受託機関市場はバイオ製薬会社と製薬会社に二分されます。製薬会社セグメントは2022年に北米の医薬品販売契約市場でより大きなシェアを占めています。

国別では、北米の医薬品販売受託市場は米国、カナダ、メキシコに区分されます。2022年の北米の医薬品販売受託機関市場は米国が支配的でした。

Aenova Holding GmbH、Axxelus Inc、CMIC Holdings Co Ltd、IQVIA Holdings Inc、Peak Pharma Solutions Inc、Pfizer Inc、Promoveo Health LLC、QFR Solutions LLC、Sales Focus Inc、Syneos Health Incは、北米の医薬品販売契約市場で事業を展開している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米の医薬品販売受託機関の市場情勢

  • PEST分析
    • 北米PEST分析

第5章 北米の医薬品販売受託機関市場：主要産業力学

  • 市場促進要因
    • デジタル技術の統合の進展
    • 製薬会社の製品販売拡大への関心の高まり
  • 主な市場抑制要因
    • アウトソーシングに伴う品質問題
  • 主な市場機会
    • 遠隔医療と遠隔明細書作成の利用の増加
  • 今後の主な動向
    • 新興市場での拡大
  • 影響分析

第6章 医薬品販売受託機関市場：北米市場分析

  • 北米の医薬品販売受託機関市場売上高、2022年～2030年

第7章 北米の医薬品販売受託機関市場：2030年までの収益と予測：サービス別

  • 商業サービス
  • 非商用サービス

第8章 北米の医薬品販売受託機関市場：2030年までの収益と予測：モジュール別

  • シンジケートモジュール
  • 専用モジュール

第9章 北米の医薬品販売受託機関市場：2030年までの収益と予測：治療領域別

  • 心血管疾患
  • がん領域
  • 代謝疾患
  • 神経学
  • 整形外科疾患
  • 感染症
  • その他

第10章 北米の医薬品販売受託機関市場：2030年までの収益と予測：エンドユーザー別

  • バイオ医薬品企業
  • 製薬会社

第11章 北米の医薬品販売受託機関市場：国別分析

  • 北米
      • 米国
      • カナダ
      • メキシコ

第12章 医薬品販売受託機関市場：業界情勢

  • 成長戦略

第13章 企業プロファイル

  • CMIC Holdings Co Ltd
  • Axxelus Inc
  • IQVIA Holdings Inc
  • Peak Pharma Solutions Inc
  • QFR Solutions LLC
  • Promoveo Health LLC
  • Syneos Health Inc
  • Aenova Holding GmbH
  • Pfizer Inc
  • Sales Focus Inc

第14章 付録

図表

List Of Tables

  • Table 1. North America Pharmaceutical Contract Sales Organizations Market Segmentation
  • Table 2. US: North America Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. US: North America Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. US: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. US: North America Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Canada: North America Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Canada: North America Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Canada: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Canada: North America Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Recent Growth Strategies in the Pharmaceutical Contract Sales Organizations Market
  • Table 15. Glossary of Terms, North America Pharmaceutical Contract Sales Organizations Market

List Of Figures

  • Figure 1. North America Pharmaceutical Contract Sales Organizations Market Segmentation, By Country
  • Figure 2. North America - PEST Analysis
  • Figure 3. North America Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. North America Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
  • Figure 7. Commercial Services: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Non-Commercial Services: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
  • Figure 10. Syndicated Modules: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Dedicated Modules: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
  • Figure 13. Cardiovascular Disorders: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Oncology: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Metabolic Disorders: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Neurology: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Orthopedic Diseases: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Infectious Diseases: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Others: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
  • Figure 21. Biopharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Pharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. North America Pharmaceutical Contract Sales Organizations Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 24. North America Pharmaceutical Contract Sales Organizations Market, By Key Countries, 2022 and 2030 (%)
  • Figure 25. US: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Canada: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Mexico: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
目次
Product Code: BMIRE00030017

The North America pharmaceutical contract sales organizations market is expected to grow from US$ 3,987.29 million in 2022 to US$ 7,614.12 million by 2030. It is estimated to record a CAGR of 8.4% from 2022 to 2030.

Increasing Integration of Digital Technologies Drives North America Pharmaceutical Contract Sales Organizations Market

The increased deployment of digital technologies fuels a transformational surge in the pharmaceutical contract sales organization (CSO) market. This fundamental change highlights the need for a tactical response to the dynamically changing pharmaceutical market. An essential component of streamlining sales operations, increasing productivity, and navigating the complexities of a healthcare environment that is becoming increasingly digitized is integrating digital tools and technologies into CSOs. With advanced customer relationship management tools, artificial intelligence, and data analytics, CSOs can gain valuable insights, customize their sales strategies, and establish deeper relationships with healthcare professionals. In addition to speeding up information transmission, the seamless integration of digital platforms allows for real-time adaptability to market trends and legislative changes. This technological change in the pharmaceutical CSO landscape represents more than just a fad; it represents a fundamental redefining of how sales tactics are developed and implemented. The adoption of digital technologies places CSOs at the forefront of innovation. It promotes a more responsive environment that aligns with the larger digital transformation sweeping the healthcare sector. The market is positioned for sustained growth as pharmaceutical CSOs continue to use the power of digitalization, propelled by a convergence of technological expertise, strategic agility, and a clear awareness of the contemporary demands of the pharmaceutical ecosystem.

North America Pharmaceutical Contract Sales Organizations Market Overview

The pharmaceutical contract sales organizations market in North America is segmented into the US, Canada, and Mexico. In 2022, the US held the largest market share in this region and is expected to continue its dominance during the forecast period. The pharmaceutical contract sales organizations market in North America is expected to grow due to the adoption of new technologies by contract sales organizations, the surging emphasis of pharmaceutical companies in boosting the sales of small-molecule and biopharmaceutical drugs, and an increase in focus on cutting down the costs incurred by in-house sales operations are the major factors driving the growth of the pharmaceutical contract sales organizations market in North America. The number of launches of new medicine has spiked over time. According to a report by IQVIA on R&D trends, 84 new active compounds were introduced globally in 2021, twice as many as introduced in the previous 5 years. The demand for contract sales services is anticipated to rise with the increase in drug releases internationally. North America accounts for the largest share of the pharmaceutical contract sales organization market. Key players such as EPS Corp.; IQVIA, Inc.; and Axxelus fuel the market in this region.

North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Million)

North America Pharmaceutical Contract Sales Organizations Market Segmentation

The North America pharmaceutical contract sales organizations market is segmented into services, modules, therapeutic area, end user, and country.

Based on services, the North America pharmaceutical contract sales organizations market is bifurcated into commercial services and non-commercial services. The commercial services segment held a larger share of the North America pharmaceutical contract sales organizations market in 2022.

Based on modules, the North America pharmaceutical contract sales organizations market is bifurcated into syndicated modules and dedicated modules. The syndicated modules segment held a larger share of the North America pharmaceutical contract sales organizations market in 2022.

Based on therapeutic area, the North America pharmaceutical contract sales organizations market is segmented into cardiovascular disorders, oncology, metabolic disorders, neurology, orthopedic diseases, infectious diseases, and others. The oncology segment held the largest share of the North America pharmaceutical contract sales organizations market in 2022.

Based on end user, the North America pharmaceutical contract sales organizations market is bifurcated into biopharmaceutical companies and pharmaceutical companies. The pharmaceutical companies segment held a larger share of the North America pharmaceutical contract sales organizations market in 2022.

Based on country, the North America pharmaceutical contract sales organizations market is segmented into the US, Canada, and Mexico. The US dominated the North America pharmaceutical contract sales organizations market in 2022.

Aenova Holding GmbH, Axxelus Inc, CMIC Holdings Co Ltd, IQVIA Holdings Inc, Peak Pharma Solutions Inc, Pfizer Inc, Promoveo Health LLC, QFR Solutions LLC, Sales Focus Inc, and Syneos Health Inc are some of the leading companies operating in the North America pharmaceutical contract sales organizations market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Pharmaceutical Contract Sales Organizations Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis

5. North America Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Increasing Integration of Digital Technologies
    • 5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products
  • 5.2 Key Market Restraints
    • 5.2.1 Quality Issues Associated with Outsourcing
  • 5.3 Key Market Opportunities
    • 5.3.1 Rising Use of Telemedicine and Remote Detailing
  • 5.4 Key Future Trends
    • 5.4.1 Expansion in Emerging Markets
  • 5.5 Impact Analysis:

6. Pharmaceutical Contract Sales Organizations Market - North America Market Analysis

  • 6.1 North America Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030

7. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Services

  • 7.1 Overview
  • 7.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
  • 7.3 Commercial Services
    • 7.3.1 Overview
    • 7.3.2 Commercial Services: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Non-Commercial Services
    • 7.4.1 Overview
    • 7.4.2 Non-Commercial Services: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Modules

  • 8.1 Overview
  • 8.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
  • 8.3 Syndicated Modules
    • 8.3.1 Overview
    • 8.3.2 Syndicated Modules: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Dedicated Modules
    • 8.4.1 Overview
    • 8.4.2 Dedicated Modules: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Therapeutic Area

  • 9.1 Overview
  • 9.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
  • 9.3 Cardiovascular Disorders
    • 9.3.1 Overview
    • 9.3.2 Cardiovascular Disorders: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Oncology
    • 9.4.1 Overview
    • 9.4.2 Oncology: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Metabolic Disorders
    • 9.5.1 Overview
    • 9.5.2 Metabolic Disorders: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Neurology
    • 9.6.1 Overview
    • 9.6.2 Neurology: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.7 Orthopaedic Diseases
    • 9.7.1 Overview
    • 9.7.2 Orthopedic Diseases: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.8 Infectious Diseases
    • 9.8.1 Overview
    • 9.8.2 Infectious Diseases: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.9 Others
    • 9.9.1 Overview
    • 9.9.2 Others: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by End User

  • 10.1 Overview
  • 10.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
  • 10.3 Biopharmaceutical Companies
    • 10.3.1 Overview
    • 10.3.2 Biopharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Pharmaceutical Companies
    • 10.4.1 Overview
    • 10.4.2 Pharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Pharmaceutical Contract Sales Organizations Market - Country Analysis

  • 11.1 North America
      • 11.1.1.1 North America Pharmaceutical Contract Sales Organizations Market, by Country
      • 11.1.1.2 US
        • 11.1.1.2.1 US: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.2.2 US: North America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
        • 11.1.1.2.3 US: North America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
        • 11.1.1.2.4 US: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
        • 11.1.1.2.5 US: North America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.3 Canada
        • 11.1.1.3.1 Canada: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.3.2 Canada: North America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
        • 11.1.1.3.3 Canada: North America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
        • 11.1.1.3.4 Canada: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
        • 11.1.1.3.5 Canada: North America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.4 Mexico
        • 11.1.1.4.1 Mexico: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.4.2 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
        • 11.1.1.4.3 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
        • 11.1.1.4.4 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
        • 11.1.1.4.5 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

12. Pharmaceutical Contract Sales Organizations Market - Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies
    • 12.2.1 Overview

13. Company Profiles

  • 13.1 CMIC Holdings Co Ltd
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Axxelus Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 IQVIA Holdings Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Peak Pharma Solutions Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 QFR Solutions LLC
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Promoveo Health LLC
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Syneos Health Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Aenova Holding GmbH
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Pfizer Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Sales Focus Inc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms